Amneal Pharmaceuticals, Inc. (AMRX) Revenue History
Amneal Pharmaceuticals, Inc. (AMRX) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2017-12-31 | $1.03B |
| 2018-12-31 | $1.66B |
| 2019-12-31 | $1.75B |
| 2020-12-31 | $2.03B |
| 2021-12-31 | $2.12B |
| 2022-12-31 | $2.21B |
| 2023-12-31 | $2.39B |
| 2024-12-31 | $2.79B |
| 2025-12-31 | $3.02B |
How AMRX compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| BMRN | BioMarin Pharmaceutical Inc. | $3.22B |
| BKD | Brookdale Senior Living Inc. | $3.19B |
| UTHR | United Therapeutics Corporation | $3.18B |
| NBIX | Neurocrine Biosciences Inc. | $2.86B |
| QDEL | QuidelOrtho Corp Com | $2.73B |
These are five companies in the same sector as AMRX with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Amneal Pharmaceuticals, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("AMRX", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | AMRX | $17.89 | -0.06% | 0.08M |
| 3 | ||||
| 4 | ||||
| 5 |